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External flavoprotein monooxygenases comprise a group of flavin-dependent
oxidoreductases that catalyze the insertion of one atom of molecular oxygen into
an organic substrate and the second atom is reduced to water. These enzymes are
involved in a great number of metabolic pathways both in prokaryotes and eukaryotes.
Flavoprotein monooxygenases have attracted the attention of researchers for several
decades and the advent of recombinant DNA technology caused a great progress in the
field. These enzymes are subjected to detailed biochemical and structural characterization
and some of them are also regarded as appealing oxidative biocatalysts for the production
of fine chemicals and valuable intermediates toward active pharmaceutical ingredients
due to their high chemo-, stereo-, and regioselectivity. Here, we review the most
representative reactions catalyzed both in vivo and in vitro by prototype flavoprotein
monooxygenases, highlighting the strategies employed to produce them recombinantly,
to enhance the yield of soluble proteins, and to improve cofactor regeneration in order
to obtain versatile biocatalysts. Although we describe the most outstanding features of
flavoprotein monooxygenases, we mainly focus on enzymes that were cloned, expressed
and used for biocatalysis during the last years.
Keywords: flavoprotein monooxygenase, Baeyer–Villiger oxidation, biooxidations, biocatalysis, sulfoxidation,
epoxidation, hydroxylation, recombinant biocatalyst
FLAVOPROTEIN MONOOXYGENASES
Flavoprotein monooxygenases comprise a family of enzymes
that participate in a wide variety of metabolic processes both
in prokaryotic and eukaryotic cells. They are involved in path-
ways of degradation of aromatic compounds, polyketides biosyn-
thesis, antibiotic resistance and, biosynthesis of compounds
with relevant biological activities as cholesterol, antibiotics, and
siderophores. Some of these enzymes participate in routes that
allow microbial utilization of organic compounds as carbon and
energy sources. Most flavoprotein monooxygenases are able to
use molecular oxygen (O2) as oxygen donor to oxygenate an
organic compound, a reaction that depends on a reduced flavin
cofactor to activate O2 by electron donation. These enzymes are
classified as external (EC 1.14.13) and internal monooxygenases
(EC 1.13.12). External monooxygenases rely on reduced coen-
zymes in the form of NADPH or NADH as sources of reducing
power for the flavin, whereas in internal monooxygenases the
flavin is reduced by the substrate itself. Besides, there are flavin-
dependent enzymes that are able to catalyze hydroxylations of
organic compounds. In this case, the flavin is required to oxi-
dize the substrate via a reaction in which the oxygen atom comes
from water while O2 serves to recycle the flavin (van Berkel
et al., 2006; Torres Pazmiño et al., 2010b). External flavoprotein
monooxygenases contain non-covalently bound FAD or FMN
and catalyze the NAD(P)H-dependent insertion of a single oxy-
gen atom into an organic substrate while the second atom of
oxygen is reduced to water. They are classified in six classes (A–F)
according to structural- and sequence-related characteristics (van
Berkel et al., 2006). Besides natural flavoproteinmonooxygenases,
modified flavins have been used as organocatalysts and novel arti-
ficial flavoenzymes have been generated by flavin re-design (de
Gonzalo and Fraaije, 2013).
In the following sections we review the most representative
reactions catalyzed by prototype flavoprotein monooxygenases,
highlighting the strategies employed to produce them recombi-
nantly. We describe the most outstanding features of bacterial
flavoprotein monooxygenases, albeit we mainly focus on enzymes
that were cloned, expressed and used for biocatalysis during the
last years.
BAEYER-VILLIGER OXIDATIONS
The oxidation of ketones is known in organic chemistry as
Baeyer-Villiger oxidation (Baeyer and Villiger, 1899). This reac-
tion involves peracids or hydrogen peroxide to achieve the
oxidation of ketones to esters or lactones. Chiral lactones are
valuable intermediates toward the synthesis of natural prod-
ucts and analogs (reviewed in de Gonzalo et al., 2010). For
Baeyer-Villiger oxidations, the enzyme-mediated transformation
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has become the preferred method due to its high enantio-, regio-,
and chemoselectivity. Besides, the process takes place in environ-
mentally friendly conditions, avoids the use of toxic reagents, and
allows scale-up. The ability of some microorganisms to grow in a
certain alcohol or ketone grabbed the attention to the enzymes
involved in those metabolic routes and prompted the discov-
ery of Baeyer-Villiger monooxygenases (BVMOs). An increasing
number of BVMOs have been identified, cloned, recombinantly
expressed, engineered and used for biocatalysis. This topic has
been the matter of very comprehensive revisions during the last
5 years (de Gonzalo et al., 2010; Torres Pazmiño et al., 2010a;
Leisch et al., 2011; Balke et al., 2012), hence the present section
focuses mainly on the strategies used to overcome gene expres-
sion problems and cofactor regeneration limitations, scale-up and
a summary of the most recent applications.
Different types of BVMOs exist. Type I BVMOs contain FAD,
depend on NADPH for catalysis and belong to the class B of flavo-
protein monooxygenases while Type II BVMOs are FMN- and
NADH-dependent enzymes and belong to class C of flavoprotein
monooxygenases. In addition, there are atypical BVMOs that do
not share their characteristics (Willetts, 1997; van Berkel et al.,
2006; Torres Pazmiño et al., 2010a). Type I BVMOs are flavoen-
zymes that catalyze the oxidation of a linear or cyclic ketone to an
ester or lactone, respectively, at the expense of molecular oxygen
and NADPH. For these enzymes NADPH is the required electron
donor. As a result, an oxygen atom is inserted into a carbon-
carbon bond adjacent to a carbonyl group in the substrate and
the other one is reduced to water. The mechanism of this reac-
tion is proposed to proceed via formation and stabilization of a
covalent bond between oxygen and the C4a of the isoalloxazine
ring of reduced FAD. This C4a-peroxyflavin performs a nucle-
ophilic attack on the carbonyl group of the substrate giving rise to
a Criegee intermediate that rearranges spontaneously to the prod-
uct (Figure 1). BVMOs can also oxygenate heteroatoms probably
via an electrophilic mechanism (reviewed in Mihovilovic, 2006;
van Berkel et al., 2006; Torres Pazmiño et al., 2008a).
In 2002, a consensus motif for Type I BVMOs was described
(Fraaije et al., 2002) that was very useful for the identification of
novel Type I BVMOs by genome mining (Torres Pazmiño et al.,
2010a). Recently, a more specific sequence motif was identified
that allowed a better distinction between typical Type I BVMOs
and flavin-containing monooxygenases (FMOs) (Riebel et al.,
2012). More than fifty Type I BVMO genes are currently available
for recombinant expression. Most of them are of bacterial origin
but the cloning of the coding sequences of few eukaryotic Type I
BVMOs has been reported during the last 2 years (Leipold et al.,
2012; Beneventi et al., 2013; Mascotti et al., 2013).
The cyclohexanone monooxygenase from Acinetobacter cal-
coaceticus NCIMB 9871 (CHMOAcineto) is a model Type I BVMO
that has been studied in-depth. It showed to be a robust biocata-
lyst, as expressed in E. coli from a pET-22b derived vector, able
to catalyze selective oxygenation of a broad variety of ketones
in desymmetrizations reactions, regiodivergent oxidations and
kinetic resolutions (reviewed in Mihovilovic, 2006; Leisch et al.,
2011). Recently, the CHMO from Rhodococcus sp. HI-31 was crys-
tallized with its substrate, cyclohexanone, and with NADP+ and
FAD at 2.4 Å resolution (Yachnin et al., 2012). A benchmark
FIGURE 1 | Catalytic mechanism of Type I Baeyer-Villiger
monooxygenases.
reaction catalyzed by E. coli cells overexpressing CHMOAcineto
was the asymmetric oxidation of the racemic bicyclo[3.2.0]hept-
2-en-6-one in large scale. For this purpose, the strategies for
optimization of the bioconversion included a fed-batch biotrans-
formation, the use of resin-based in situ substrate feeding and
product removal (SFPR) technology, a fine control of the bio-
process and a proper aeration. This bioconversion was scaled-up
to pilot-plant scale (200 L) and 4.5 g/L of lactone were produced
(Baldwin et al., 2008). The SFPR methodology allows the use of
substrate concentrations beyond toxicity levels and avoids inhibi-
tion of the reaction by the product or substrate as their concen-
trations in the culture remains below inhibitory levels. Scale-up
methodologies for Baeyer-Villiger biooxidation of ketones were
reviewed in de Gonzalo et al. (2010). An innovative monitor-
ing system was developed based on the use of flow-calorimetry
to measure temperature changes due to Baeyer–Villiger oxygena-
tions catalyzed by encapsulated E. coli expressing CHMOAcineto
(Bucˇko et al., 2011). Variants of CHMOAcineto with enhanced
oxidative and thermal stabilities were obtained by rational and
combinational mutagenesis atM and C residues without affect-
ing the activity or selectivity of the enzyme (Opperman and
Reetz, 2010). In addition, wild-type and mutant CHMOAcineto
catalyzed the conversion of 4-ethylidenecyclohexanone into E-
and Z-configured lactones, respectively, and successive reactions
catalyzed by transition metals were used to produce different
trisubstituted E- or Z-olefins (Zhang et al., 2013). E. coli cells
expressing the CHMO from Xanthobacter sp. ZL5 (CHMOXantho)
have a very broad substrate acceptance profile and the ability
to convert some bulky ketones not accepted by other BVMOs
(Rial et al., 2008a,b). More recently, Alexander et al. (2012)
reported the cloning and evaluation of a CHMO from the
xenobiotic-degrading Polaromonas sp. JS666. Initial oxidation
assays showed no results due to formation of inclusion bodies but
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upon optimization, a detailed screening of the biocatalyst could
be performed (Table 1).
The cyclopentanone monooxygenase from Comamonas sp.
NCIMB 9872 (CPMO) is another cycloketone-converting BVMO,
which can display enantiodivergent transformations with respect
to the CHMO group. E. coli cells overexpressing the gene cod-
ing for CPMO were used as biocatalysts to oxidize an oxo-
bridged ketone in order to obtain a heterobicyclic lactone, a
key intermediate in formal total syntheses of various natu-
ral products containing a tetrahydrofuran structural motif such
as trans-kumausyne, goniofufurone analogs and showdomycin
(Mihovilovic et al., 2006). In this work, the biotransformation
was carried out in a bioreactor using the in situ SFPR technol-
ogy and the desired lactone was obtained in 70 % isolated yield
(Mihovilovic et al., 2006). In a recent report, CHMOXantho- and
CPMO-mediated biooxidations of a bridged-bicyclic ketone were
performed in shake-flasks scale and allowed access to both antipo-
dal lactones in very good yields and high enantiomeric excess
(e.e.). These chiral lactones were key intermediates toward (+)
and (−) non-natural carba-C-nucleosides in high optical purity
(Bianchi et al., 2013).
Other remarkable Type I BVMOs is the phenylacetone
monooxygenase from Thermobifida fusca (PAMO) (Table 1). Its
coding sequence was cloned and expressed in E. coli from a
pBAD/myc-HisA-derived vector (Fraaije et al., 2005). PAMO can
tolerate high temperatures and organic solvents (Fraaije et al.,
2005; de Gonzalo et al., 2006a). The enzyme was purified, charac-
terized and it was the first BVMO for which the three-dimensional
structure was elucidated by X-ray diffraction (Malito et al., 2004).
Some years afterward, Orru et al. (2011) solved the crystal struc-
ture of reduced and oxidized PAMO in complex with NADP+.
Since the substrate profile of wild-type PAMO is mainly limited
to some aromatic ketones and sulfides (de Gonzalo et al., 2005b;
Rodríguez et al., 2007; Zambianchi et al., 2007), protein engineer-
ing strategies were undertaken aiming at expanding the substrate
profile of PAMO without affecting its stability (Bocola et al.,
2005). By a site-directed mutagenesis approach it was possible
to expand the substrate range of the enzyme to some prochi-
ral cyclic ketones, sulfides, and amines (Torres Pazmiño et al.,
2007). Thermostable PAMOmutants with high activity and enan-
tioselectivity for the conversion of 2-substituted cyclohexanones
derivatives were produced by saturation mutagenesis focused on
specific sites of PAMO (Reetz and Wu, 2009; Wu et al., 2010).
Directed evolution and rational re-design of PAMO and other
BVMOs were thoroughly reviewed recently (Zhang et al., 2012).
It has been reported that the addition of organic co-solvents
to biotransformations can influence conversion and selectivity
of reactions catalyzed by wild-type PAMO and variants (Rioz-
Martínez et al., 2008, 2009, 2010b). Recently, de Gonzalo et al.
(2012) improved the biocatalytic performance of a PAMOmutant
(the variant with M446 replaced by G) in hydrophilic organic
solvents and, including a weak anion exchange resin, they were
able to attain the dynamic kinetic resolution of a range of ben-
zylketones. Further optimization of PAMO biooxidations con-
sidered the buffer and ionic strength of the reaction media as
well as the coupled reaction for cofactor regeneration (Rodríguez
et al., 2012). To improve the biocatalyst performance, funda-
mental aspects of protein expression such as host strain, inducer
concentration, temperature and length of induction as well as
riboflavin addition were considered (van Bloois et al., 2012). This
approach also evaluated biotransformation conditions including
external sugars as sources of reducing power for NADPH regen-
eration, substrate concentration and, biotransformation temper-
ature and length. Recently, Dudek et al. (2013b) developed a
screening method based on periplasmically expressed PAMO
aiming at enabling complete access of substrates to the enzyme
and facilitating NADPH recycling by externally added phosphite
dehydrogenase (PTDH) from Pseudomonas stutzeri WM88. The
pamO gene was cloned into a pBAD-derived plasmid between
an N-terminal Tat-dependent signal sequence of the endoge-
nous E. coli protein TorA and a C-terminal Myc epitope/His-
tag. The Tat-PAMO protein was functionally expressed in the
periplasm of E. coli cells and this system was used together
with the PTDH-based regeneration system for biotransforma-
tions. Just recently, this analysis was extended to the screening
of a library of PAMO mutants, which resulted in the isola-
tion of a quadruple mutant with the same thermostability as
the wild-type enzyme but with an extended substrate scope
(Dudek et al., 2013a) (Table 1).
Another available BVMO is the cyclopentadecanone
monooxygenase from Pseudomonas sp. HI-70 (CPDMO).
Its gene was cloned in 2006 and initial assays detected activity
toward large ring ketones (C11-C13), substituted cyclohexanones
(Iwaki et al., 2006) and ketosteroids (Beneventi et al., 2009). The
biocatalytic performance of CPDMO was evaluated extensively
in 2011 and showed a behavior similar to CHMO within desym-
metrizations and kinetic resolutions, but performed particularly
interesting in regiodivergent oxidations (Fink et al., 2011).
Another robust biocatalyst is cyclododecanone monooxygenase
from Rhodococcus ruber SC1 (CDMO), which was used as a case
study to show the potentials of a new tool for chiral catalysts
assessment (Fink et al., 2012). The 4-hydroxyacetophenone
monooxygenase (HAPMO) from Pseudomonas fluorescens ACB
has been available for many years (Kamerbeek et al., 2001).
In 2009, the gene encoding for a HAPMO from Pseudomonas
putida JD1 was cloned, functionally expressed and characterized
(Rehdorf et al., 2009). Soluble protein production was prob-
lematic thus several strategies were undertaken to circumvent
this limitation. Expression of the HAPMO-encoding gene was
assayed from two different plasmids and in several bacterial hosts,
in media with different composition, at various temperatures,
in the presence or absence of FMN and by co-expression with
molecular chaperones. By biotransformations in crude cell
extracts it was found that this enzyme preferentially oxidizes
aryl-aliphatic ketones (Rehdorf et al., 2009). In a following work,
the biooxidation of the aromatic ketone 3-phenyl-2-butanone
was scaled-up in a bioreactor and yields improved by the use of
adsorbent resins for an in situ SFPR (Geitner et al., 2010).
Other BVMOs have been newly reported (Table 1). A set of
predicted 22 bvmo-encoding genes from Rhodococcus jostii RHA1
were cloned but only 12 of them could be expressed as soluble
active enzymes (Szolkowy et al., 2009). However, by applying a
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Table 1 | Baeyer-Villiger oxidation.
Enzyme Gene Expression system Referencesa
CHMO chmo from Polaromonas sp.
JS666
E. coli BL21 Star
(DE3)/pET101/D-TOPO vector
Alexander et al., 2012
mutants of chnB from A.
calcoaceticus NCIMB 9871
E. coli BL21-Gold (DE3)/pET22b Opperman and Reetz, 2010
chnB from A. calcoaceticus
NCIMB 9871 and pos5 (NADH
kinase) from S. cerevisiae
CEN.PK2-1D
E. coli BL21(DE3)/pET22b (chnB)
and ACYCDuet-1 (pos5)
Lee et al., 2013
chnB from A. calcoaceticus
NCIMB 9871 and gapB
(NADP+-dependent GAPDH) from
B. subtilis
E. coli (gapA null,
NAD+-dependent
glyceraldehyde-3-phosphate
dehydrogenase mutant)/pET22b
(chnB) and pDHC29 (gapB)
Wang et al., 2013
PAMO different pamO mutants from
T. fusca
E. coli TOP10/pBAD/myc-HisA Wu et al., 2010
different mutant pamO from
T. fusca
E. coli TOP10/pBAD/myc-HisA Dudek et al., 2011
wild-type and mutant pamO from
T. fusca
E. coli TOP10/pBAD-Tat-AldO
(periplasmic expression)
Dudek et al., 2013a,b
BVMO 22 bvmo genes from R. jostii
RHA1 (16 BVMOs with
demonstrated activity)
E. coli TOP10/pBADN and pCRE2
(with phosphite dehydrogenase
gene)
Riebel et al., 2012
bvmo from A. radioresistens S13 E. coli BL21(DE3)/pT7 expression
vector
Minerdi et al., 2012
STMO wild-type and mutant stmo from
R. rhodochrous
E. coli BL21(DE3)
CodonPlus/Champion pET-vector
Franceschini et al., 2012
wild-type stmo from R.
rhodochrous
E. coli BL21(DE3)/pET28b Leipold et al., 2013
SAPMO SAPMO from C. testosteroni KF1 E. coli BL21 Star
(DE3)/pET101/D-TOPO vector
Weiss et al., 2013
OTEMO OTEMO gene from P. putida
NCIMB 10007
E. coli BL21(DE3)/pET28b Kadow et al., 2012
OTEMO gene from P. putida
ATCC 17453
E. coli BL21(DE3)/pSD80 Leisch et al., 2012
2,5-
DKCMO
2,5-DKCMO gene from P. putida
NCIMB 10007
E. coli BL21(DE3)/pET28b Kadow et al., 2011, 2012
3,6-
DKCMO
3,6-DKCMO gene from P. putida
NCIMB 10007
E. coli BL21(DE3)/pET28b
(coexpression of GroES-GroEL
chaperones)
Kadow et al., 2012
2,5- and
3,6-
DKCMO
2,5- and 3,6-DKCMO genes from
P. putida NCIMB 10007 and Fre
gene from E. coli
E. coli BL21(DE3)/pET28b
(DKCMOs, coexpression of
GroES-GroEL); pGas (Fre or fusion
genes, L-rhamnose inducible)
Kadow et al., 2013
(Continued)
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Table 1 | Continued
Enzyme Gene Expression system Referencesa
BVMO
type II
camE25−1, camE25−2, camE36
and Fred gene from P. putida
ATCC 17453
E. coli BL21(DE3)/pSD80 (each
camE gene and tandem clones);
E. coli BL21(DE3) pLysS/pET17b
(Fred gene)
Iwaki et al., 2013
FMO
(type II)
fmo from S. maltophilia E. coli
BL21(DE3)/pET-YSBL-LIC-3C
Jensen et al., 2012
several fmo genes from R. jostii
RHA1
E. coli/pBADN and pCRE2 Riebel et al., 2013a,b
aThe information shown corresponds to reports as of 2010.
Abbreviations: 3,6-DKCMO, 3,6-diketocamphane 1,6-monooxygenase; 2,5-DKCMO, 2,5-diketocamphane 1,2-monooxygenase; ACMO, acetone monooxygenase;
BVMO, Baeyer-Villiger monooxygenase; CDMO, cyclododecanone monooxygenase; CHMO, cyclohexanone monooxygenase; CPMO, cyclopentanone monooxy-
genase; FMO, flavin-containing monooxygenase; OT, 2-oxo-3-4,5,5-trimethylcyclopentenylacetic acid; OTEMO, 2-oxo-3-4,5,5-trimethylcyclopentenylacetyl-CoA
monooxygenase; PAMO, phenylacetone monooxygenase; SAPMO, 4-sulfophenyl acetate monooxygenase; STMO, steroid monooxygenase.
high-throughput cloning strategy and optimized expression con-
ditions Riebel et al. (2012) were able to express the 22 probable
bvmo genes identified in the genome of R. jostii RHA1 in sol-
uble form. They cloned the selected genes under the control
of araBAD promoter directly or as a fusion with the PTDH
gene (Riebel et al., 2012). Other recently expressed bvmo genes
include the almA gene from Acinetobacter radioresistens S13 that
encodes a BVMO involved in the subterminal oxidation of alkanes
(Minerdi et al., 2012), a steroid monooxygenase (STMO) from
Rhodococcus rhodochrous which crystal structure (Franceschini
et al., 2012) and substrate profile (Leipold et al., 2013) were deter-
mined, a 4-sulfoacetophenone monooxygenase (SAPMO) from
Comamonas testosteroni KF-1 that is involved in the biodegra-
dation of 4-sulfophenylcarboxylates (Weiss et al., 2013), and the
2-oxo-3-4,5,5-trimethylcyclopentenylacetyl-CoA monooxyge-
nase (OTEMO) from P. putidaNCIMB 10007 (Kadow et al., 2012)
and from P. putida ATCC 17453 (Leisch et al., 2012). This enzyme
participates in the degradation of camphor in the native microbial
host but, recombinantly expressed in E. coli, it is able to accept
α,β-unsaturated monocyclic and bicyclic ketones (Kadow et al.,
2012).
The strict dependence of BVMOs on NADPH for cataly-
sis certainly impairs the practical applications of these enzymes
due to the high costs of NADPH or to the requirement of a
cofactor regeneration system. The possibility to carry out the
desired biotransformation in whole-cell systems is a beneficial
alternative since the cell itself provides the NADPH. The co-
expression of glucose-6-phosphate dehydrogenase or the addition
of carbohydrates to the culture media can improve NADPH
regeneration by the host cells (Walton and Stewart, 2002; Lee
et al., 2007). Besides, several other options are available to
regenerate NADPH for BVMO activity (recently reviewed in de
Gonzalo et al., 2010). Some coenzyme regeneration systems are
based on a coupled enzymatic reaction that produces NADPH at
the expense of an auxiliary substrate. Typical pure enzymes used
for the regeneration of NADPH include glucose-6-phosphate
dehydrogenase, PTDH, alcohol dehydrogenase and glucose dehy-
drogenase. However, these systems need to be added to the
activity assays. In the last years, an alternative strategy was devel-
oped in which fusion proteins between a PTDH and certain
BVMOs were produced and evaluated as self-sufficient biocat-
alysts (Torres Pazmiño et al., 2008b, 2009). Other approaches
based on the chemical (de Gonzalo et al., 2005a) or photochemi-
cal (Hollmann et al., 2007) regeneration of the flavin bound to the
BVMO have also been investigated. Most recently, two strategies
to improve NADPH regeneration were presented and tested in
BVMO-mediated biotransformations (Table 1). In one approach,
a NADH kinase from yeast was used for the direct phosphoryla-
tion of NADH to NADPH in E. coli cells producing CHMOAcineto
(Lee et al., 2013). This approach enhanced the oxidation of
cyclohexanone in a fed-batch biotransformation and doubled the
productivity of ε-caprolactone when compared with the control
lacking the NADH kinase (Lee et al., 2013). The other approach
proposed a strategy to increase NADPH bioavailability by replac-
ing the native NAD+-dependent glyceraldehyde-3-phosphate
dehydrogenase gapA gene in E. coli with a NADP+-dependent
gapB gene from Bacillus subtilis, hence producing in E. coli a
NADP+-dependent glyceraldehyde-3-phosphate dehydrogenase
from a plasmid and the CHMOAcineto from a compatible expres-
sion vector (Wang et al., 2013).
Two additional BVMOs (named 2,5-diketocamphane
1,2-monooxygenase (2,5-DKCMO) and 3,6-diketocamphane
1,6-monooxygenase (3,6-DKCMO)) that participate in the
camphor-degrading metabolic route in P. putida NCIMB 10007
are Type II BVMOs (Kadow et al., 2011, 2012). They are
two-component systems consisting of a monooxygenase and a
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reductase, and depend on FMN- and NADH for activity. The
genes encoding the monooxygenase subunit of 2,5-DKCMO and
3,6-DKCMO were recombinantly expressed in E. coli (Kadow
et al., 2011, 2012). The expression of the gene encoding the oxyge-
nase subunit of 3,6-DKCMO required the assistance of molecular
chaperones for enhanced soluble expression (Kadow et al., 2012)
(Table 1). These biocatalysts were able to convert mainly bicyclic
ketones. Three camE genes from P. putida ATCC 17453 coding
for different monooxygenase subunits of DKCMO isoenzymes
were cloned and expressed (Iwaki et al., 2013). In addition, one
FMN reductase (Fred) gene from the same bacteria was identified
and cloned individually or in tandem with the respective 2,5-,
or 3,6-DKCMO-coding genes. Pairs DKCMO-Fred were able to
convert bicyclic ketones with enantiomeric specificity in recom-
binant whole-cell systems (Iwaki et al., 2013) (Table 1). Recently,
a flavin-reductase Fre from E. coli was reported as an appropriate
partner for providing reduced FMN to either 2,5- or 3,6-DKCMO
from P. putida NCIMB 10007. Couples DKCMO-Fre were able to
oxidize camphor and norcamphor in the presence of NADH gen-
erated by formate dehydrogenase (FDH) from Candida boidinii
(Kadow et al., 2013).
Besides BVMOs, FMOs are capable of catalyzing Baeyer-
Villiger oxidations (Table 1). Jensen et al. (2012) reported the
ability of an FMO from Stenotrophomonas maltophilia (SMFMO)
to catalyze some Baeyer-Villiger oxidations as well as sulfoxida-
tions and to use both NADH and NADPH. The codon-optimized
synthetic gene was cloned and SMFMO was produced in E.
coli, purified and its crystal structure elucidated. Just recently,
Riebel et al. (2013a) cloned, expressed in E. coli and explored
the catalytic potential of several novel flavoprotein monooxyge-
nases from R. jostii RHA1 with homology to FMOs. The authors
studied the ability of the novel enzymes, classified as Type II
FMOs, to convert phenylacetone, (±)-bicyclo[3.2.0]hept-2-en-6-
one and methyl phenyl sulfide (thioanisole). These results were
further extended by in-depth screening in whole-cell systems
(Riebel et al., 2013b).
EPOXIDATIONS
Epoxides are valuable precursors for synthetic applications
toward bioactive compounds, thus in this section we describe
attractive epoxidations carried out by recombinant flavoprotein
monooxygenases.
Two-component styrene monooxygenases belong to the class
E of flavoprotein monooxygenases (Table 2). The first step in the
metabolic utilization of styrene in Pseudomonas sp. VLB120 is
catalyzed by an oxygenase (StyA) and a NADH-flavin oxidore-
ductase (StyB). The genes coding for this enzyme (StyAB) were
identified, cloned and expressed in E. coli (Panke et al., 1998).
In order to investigate the relationships between styrene epoxi-
dation, StyAB production, cell growth and carbon metabolism,
two-liquid-phase continuous cultures of E. coli expressing styAB
genes of Pseudomonas sp. VLB120 were performed in a 3 L-stirred
reactor (Bühler et al., 2008). The two-phase systemmade possible
the operation of the biocatalyst at subtoxic non-inhibitory sub-
strate and product concentrations. It also allowed control of the
epoxidation rate by varying styrene feed concentration (Bühler
et al., 2008). In order to improve styrene biotransformation by E.
coli expressing the two-component styrene monooxygenase from
P. putida CA-3, the corresponding coding gene was subjected
to in vitro evolution followed by an indole bioconversion-based
screening (Gursky et al., 2010). Ukaegbu et al. (2010) reported the
X-ray crystal structure of the N-terminally His-tagged oxygenase
subunit of the styrene monooxygenase from P. putida S12. Based
on this structural data and aiming at improving the preference of
the enzyme toward α-substituted styrene, point mutations were
introduced in the styrene monooxygenase from Pseudomonas sp.
LQ26 (Lin et al., 2010, 2011a,b) by site-directed mutagenesis
(Qaed et al., 2011). This procedure allowed the development of
mutants with increased reactivity toward α-substituted styrene
derivatives. By a similar rational design approach, a different set
of mutations was found to exhibit increased epoxidation activity
toward styrene and trans-β-methyl styrene compared with the
wild-type enzyme. Interestingly, one of these mutants showed
Table 2 | Epoxidation.
Enzyme Gene Expression system Referencesa
SMO wild-type and mutant styAB
fragment from P. putida CA-3
E. coli XL-10
Gold/pBluescript II KS; E.
coli BL21(DE3)/pRSET-B
Gursky et al., 2010
wild-type and several mutant
styAB2 from Pseudomonas sp.
LQ26
E. coli
BL21(DE3)/pET28a
Lin et al., 2010, 2011a, 2012
different mutant styAB2 from
Pseudomonas sp. LQ26
E. coli
BL21(DE3)/pET28a
Qaed et al., 2011
styA1/StyA2B from R. opacus
1CP
E. coli BL21(DE3)
pLysS/pET16bP
Tischler et al., 2009, 2010
aThe information shown mainly corresponds to reports as of 2010.
Abbreviation: SMO, styrene monooxygenase.
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reversed enantiomeric preference toward 1-phenylcyclohexene
(Lin et al., 2012) (Table 2).
van Hellemond et al. (2007) reported the discovery of a
novel styrene monooxygenase (SmoA) in a metagenomic library
derived from loam soil. In vitro activity assays using crude cell
extracts of bacteria producing SmoA evidenced epoxidation of
styrene and styrene derivatives to the corresponding (S)-epoxides
with excellent e.e. In Rhodococcus opacus 1CP, a self-sufficient
styrene monooxygenase was reported that harbors in the same
polypeptide chain a monooxygenase and a NADH-flavin oxi-
doreductase (StyA2B) (Tischler et al., 2009). Moreover, a multi-
functional monooxygenase system (StyA1/StyA2B) was recently
described in the same microorganism as composed of a sin-
gle styrene monooxygenase (StyA1) and the StyA2B polypeptide
(Tischler et al., 2010) (Table 2). Purified StyA2B was able to oxi-
dize styrene, 2-chlorostyrene, 3-chlorostyrene, 4-chlorostyrene,
4-methylstyrene, and dihydronaphthalene.
Surprisingly, the epoxidation of an electron-rich C=C
functionality in the oxo-bridged bicyclic ketone (1R,5S)-8-
oxabicyclo[3.2.1]oct-6-en-3-one was catalyzed by CHMOXantho,
representing the first report of a BVMO involved in this conver-
sion (Rial et al., 2008a).
SULFOXIDATIONS
Enantioselective sulfoxidations are difficult to accomplish chem-
ically and, therefore enzyme-mediated sulfoxidations have
attracted the attention of chemists and biochemists during the last
decades.
In 2007, it was shown that crude cell extracts of bacteria
producing SmoA can catalyze sulfoxidation reactions with high
enantioselectivity toward aromatic sulfides (van Hellemond
et al., 2007). The multifunctional monooxygenase system
StyA1/StyA2B from R. opacus 1CP (Tischler et al., 2009, 2010) is
also capable of oxidizing thioanisole (Table 3). In addition, oxida-
tion of sulfides can be readily catalyzed by E. coli cells expressing
the two-component NADH-dependent styrene monooxygenase
from P. putida CA-3 (Nikodinovic-Runic et al., 2013). Boyd
et al. (2012) have demonstrated that this biocatalyst is able to
S-oxidize benzo[b]thiophene and, other nine sulfur-containing
compounds, including thioanisole and some substituted analogs,
benzo[b]thiophene, and 2-methylbenzo[b]thiophene were
accepted as substrates as well (Nikodinovic-Runic et al., 2013).
The enzyme that had been previously engineered for improved
alkene epoxidation (Gursky et al., 2010) showed an increased
S-oxidation capability when compared with the wild-type form,
being the sulfur atom in the thiophene ring a better target than
the sulfur atom in an alkyl chain (Nikodinovic-Runic et al., 2013).
The BVMOs are also capable of stereoselective sulfoxidations.
In 2005, the ability of PAMO to oxidize aromatic sulfides was
proved but the sulfoxides displayed poor e.e. (de Gonzalo et al.,
2005b; Fraaije et al., 2005). The enzymatic oxidation of sul-
fides mediated by pure PAMO from T. fusca, HAPMO from P.
fluorescens ACB and ethionamide monooxygenase (EtaA) from
Mycobacterium tuberculosis was evaluated in several aqueous-
organic media (de Gonzalo et al., 2006a). More recently, the
HAPMO from P. putida JD1 was challenged in the sulfoxida-
tion of methyl-4-tolyl sulfide using crude cell extracts (Rehdorf
et al., 2009) and, the repertoire of chiral sulfoxides accessed
was extended by using both PAMO and HAPMO from P. flu-
orescens ACB as crude cell-free extracts (Rioz-Martínez et al.,
2010a). The stereoselectivity of PAMO-mediated oxidation of
several prochiral thio-ethers has been enhanced bymutagenesis of
M446 to G (Torres Pazmiño et al., 2007) and solvent engineering
methodologies were explored in order to expand the applica-
tions of wild-type and M446G PAMO (de Gonzalo et al., 2012).
The oxidation of benzyl methyl sulfide was evaluated in seven-
teen combinations of buffer/co-solvent and compared with the
reaction in aqueous medium. The reaction in Tris-HCl pH 9.0
containing 5 % methanol rendered the corresponding sulfoxide
in high conversion and good e.e. with only low levels of sul-
fone as by-product (de Gonzalo et al., 2012). Besides, Rodríguez
et al. (2012) analyzed the effect of several enzymatic cofactor
regeneration systems and cofactor concentrations in the oxidation
of thioanisole by PAMO. By protein engineering, amino acidic
positions were identified in PAMO that alter conversion and selec-
tivity of S-oxidations (Dudek et al., 2011). In this investigation,
the bulky prochiral benzyl phenyl sulfide, which is only very poor
substrate for wild-type PAMO, was readily oxidized by theM446G
mutant (Dudek et al., 2011). Therefore, it was selected as sub-
strate to evaluate periplasmic expression of PAMO variants in
order to establish a whole-cell screening method for the assess-
ment of libraries of PAMO toward the identification of mutants
with altered biocatalytic performances (Dudek et al., 2013a,b).
Nine BVMOs from R. jostii RHA1 that were cloned and
expressed by Riebel et al. (2012) showed confirmed S-oxidation
activity on thioanisole, benzyl phenyl sulfide, benzyl ethyl sul-
fide or ethionamide. Besides, the BVMO coded by the gene almA
from A. radioresistens S13 is also able to act on ethionamide to
give the corresponding S-oxide (Minerdi et al., 2012) (Table 3).
Most recently, the oxidation of thioanisole by CHMOAcineto was
investigated using FDH as NADPH recycling system (Zhai et al.,
2013). The authors constructed a whole-cell biocatalyst able to co-
express the chmoAcineto and a modified fdh gene from C. boidinii
that can utilize NADP+ efficiently. Several conditions including
concentration of the biocatalyst and substrate, pH, temperature
and time of reaction as well as addition of dimethylsulfoxide
and NADP+ were evaluated to optimize the biocatalytic reaction
(Zhai et al., 2013).
The mFMO from Methylophaga sp. SK1 was the first bacte-
rial Type I FMO reported in the literature (Choi et al., 2003).
The authors cloned, expressed and characterized the recombinant
enzyme. They determined its activity on N- and S-containing
compounds such as trimethylamine and thiourea and empha-
sized its ability to produce indigo blue. Alfieri et al. (2008)
noted an unexpected activity of this enzyme on dimethylsul-
foxide. Few years later, Rioz-Martínez et al. (2011) reported
the fusion of an optimized and thermostable PTDH with the
mFMO from Methylophaga sp. SK1 and evaluated its ability
to act on several prochiral sulfides using NADPH as electron
donor. Amongst the accepted sulfides, thioanisole was the best
substrate but the chiral sulfoxides were obtained in moderate
e.e. Some substituted thioanisole derivatives as well as other
(hetero)aromatic sulfides and alkyl butyl sulfides were also oxi-
dized to the corresponding sulfoxides, showing moderate to very
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Table 3 | S-oxidation.
Enzyme Gene Expression system Referencesa
SMO styA1/StyA2B from R. opacus
1CP
E. coli BL21(DE3)
pLysS/pET16bP
Tischler et al., 2009, 2010
wild-type and mutant styAB
fragment from P. putida CA-3
E. coli BL21(DE3)/pRSET-B Gursky et al., 2010; Boyd et al., 2012;
Nikodinovic-Runic et al., 2013
PAMO different mutant pamO from T.
fusca
E. coli
TOP10/pBAD/myc-HisA
Dudek et al., 2011
wild-type and mutant pamO from
T. fusca
E. coli TOP10/pBAD-Tat-AldO
plasmid (periplasmic
expression)
Dudek et al., 2013a,b
BVMO 9 bvmo genes from R. jostii RHA1 E. coli TOP10/pBADN and
pCRE2 (phosphite
dehydrogenase gene)
Riebel et al., 2012
bvmo gene from A. radioresistens
S13
E. coli BL21(DE3)/pT7
expression vector
Minerdi et al., 2012
FMO
(type I)
fmo from Methylophaga sp. SK1 E. coli TOP10/pCRE2 (soluble
NADPH regenerating
phosphite dehydrogenase)
Rioz-Martínez et al., 2011
tmm gene from M. silvestris E. coli BLR(DE3)
pLysS/pET28a
Chen et al., 2011
FMO
(type II)
fmo gene from S. maltophilia E. coli
BL21(DE3)/pET-YSBL-LIC-3C
Jensen et al., 2012
several fmo genes from R. jostii
RHA1
E. coli/pBADN and pCRE2 Riebel et al., 2013a
CHMO chmo gene from A. calcoaceticus
NCIMB 9871 and mutant fdh
(formate dehydrogenase) gene
from C. boidinii
E. coli BL21(DE3)/pET22b
(chmo) and pACYCDuet-1 (fdh
or both genes in tandem)
Zhai et al., 2013
aThe information shown mainly corresponds to reports as of 2010.
Abbreviations: BVMO, Baeyer-Villiger monooxygenase; FMO, flavin-containing monooxygenase; CHMO, cyclohexanone monooxygenase; fdh, formate dehy-
drogenase; HAPMO, 4-hydroxyacetophenone monooxygenase; PAMO, phenylacetone monooxygenase; SMO, styrene monooxygenase; tmm, trimethylamine
monooxygenase.
good enantioselectivity (Rioz-Martínez et al., 2011). Another
bacterial FMO, the trimethylamine monooxygenase TMM from
Methylocella silvestris, was cloned, functionally expressed in E. coli
and evaluated in the oxidation of dimethylsulfide and dimethyl-
sulfoxide (Chen et al., 2011).
The recently described Type II FMOs are also able to oxidize
sulfides, as it was shown for the SMFMO from S. maltophilia
on thioanisole, p-tolyl methyl sulfide, o- and p-chlorophenyl
methyl sulfide, benzyl methyl sulfide, and phenyl ethyl sulfide
and, for the set of R. jostii Type II FMOs on thioanisole mainly
(Jensen et al., 2012; Riebel et al., 2013a).
It is worth noting that de Gonzalo et al. (2011) created
artificial flavoenzymes that behaved as self-sufficient flavoprotein
monooxygenases capable of stereocomplementary hydrogen
peroxide-driven sulfoxidations by reconstitution of the apo form
of a riboflavin-binding protein isolated from eggs with modified
flavin derivatives.
N-HYDROXYLATIONS AND N-OXIDATIONS
N-hydroxylating flavoprotein monooxygenases (NMOs) mediate
the FAD-dependent oxidationof amines usingNADPHas electron
donor in the presence ofmolecular oxygen. Typical representatives
are L-ornithine hydroxylases and L-lysine hydroxylases.
In Pseudomonas aeruginosa, L-ornithine hydroxylase catalyzes
the hydroxylation of the side chain amine of L-ornithine to pro-
duce the corresponding hydroxylamine, the initial step in the
biosynthesis of the siderophore pyoverdine. After further modi-
fications the hydroxylamine produces a hydroxymate functional
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group that is able to chelate ferric ions. The gene coding for
L-ornithine hydroxylase (PvdA) from P. aeruginosa PAO1 was
cloned and overexpressed in E. coli as a His-tagged fusion (Ge and
Seah, 2006; Meneely and Lamb, 2007). The authors characterized
it biochemically and its specificity toward several amino acids was
investigated. In 2011, two structures of this enzyme, one in its oxi-
dized state and the other in its reduced state, were presented for
the first time (Olucha et al., 2011). An L-ornithine hydroxylase
was identified in the proteome of R. jostii RHA1 (Bosello et al.,
2012) and, its coding sequence was cloned and expressed from a
pBAD-based expression vector just recently (Riebel et al., 2013a).
The Type I mFMO from Methylophaga sp. SK1 is capable of
N-oxygenations as it was demonstrated for trimethylamine, cys-
teamine, thiourea, and other N-containing compounds (Choi
et al., 2003; Alfieri et al., 2008). This activity on trimethylamine
was further explored upon fusion of mFMO with the PTDH
for self-sufficient cofactor regeneration (Rioz-Martínez et al.,
2011). The TMM from M. silvestris was also active on methy-
lated amines such as trimethylamine and dimethylamine (Chen
et al., 2011). This enzyme is proposed to catalyze the oxidation
of trimethylamine to trimethylamine N-oxide both in eukary-
otes and prokaryotes. In the same work, the authors extended
the substrate analysis to four additional bacterial TMMs from
Roseovarius sp. 217, Ruegeria pomeroyiDSS-3, Pelagibacter ubique
HTCC1002, and P. ubique HTCC7211, which were cloned from
genomic DNA or synthetic genes, recombinantly expressed and
purified from E. coli (Chen et al., 2011).
HYDROXYLATIONS
The 4-hydroxybenzoate hydroxylases (PHBH) are classified as
class A of flavoprotein monooxygenases, they are encoded by
a single gene and contain tightly bound FAD to the sole
dinucleotide binding domain present in these enzymes. They
depend on NADPH or NADH as electron donors for flavin
reduction. Prototype enzymes are PHBH from P. fluorescens
andP. aeruginosa. Physiologically, PHBH participates in routes
of degradation of aromatic carbon compounds in soil bacteria
by catalyzing the hydroxylation in position 3 of the activated
4-hydroxybenzoate to generate 3,4-dihydroxybenzoate (protocat-
echuate) that finally enters the β-ketoadipate pathway. The genes
encoding the PHBH from P. aeruginosa and P. fluorescens were
cloned and expressed in E. coli more than 20 years ago (Entsch
et al., 1988; van Berkel et al., 1992). More recently, by means
of a combinatorial mutagenesis approach starting from avail-
able single mutations of the PHBH from P. fluorescens NBRC
14160 multiple properties of the enzyme were simultaneously
improved (Suemori and Iwakura, 2007). Subsequently, 53 con-
served residues from 92-aligned PHBH primary sequences and
19 non-conserved but presumable functional residues from P.
fluorescens NBRC 14160 PHBH were substituted with each of
the natural amino acids and, activity as well as NADPH reac-
tion specificity were evaluated (Suemori, 2013). Recently, the
genes coding for a 4-hydroxybenzoate hydroxylase (pobA) and a
3-hydroxybenzoate hydroxylase (mobA) from the moderate halo-
phyte Chromohalobacter sp. HS-2 were cloned and overexpressed
in E. coli (Kim et al., 2012). They are part of a cluster con-
taining the genes responsible for the metabolism of benzoate
and hydroxybenzoate in this bacterium (Kim et al., 2008, 2012).
Both genes were cloned into the pET-28a(+) vector in order to
obtain a fusion to a carboxyl-terminal His-Tag. Initial overex-
pression experiments gave mostly insoluble His-tagged proteins.
Therefore, the culture was subjected to heat shock to induce the
expression of E. coli DnaK and DnaJ molecular chaperones prior
to IPTG-dependent expression of the hydroxylase genes in an
attempt to improve protein solubility. Bioconversion of 4- or 3-
hydroxybenzoates to protocatechuate was tested in resting cells
producing the recombinant 4- or 3-hydroxybenzoate hydroxylase,
respectively. The authors reported an increase in product for-
mation, reflected in enhanced bioconversion efficiency, when the
reaction was carried out after heat-induction of molecular chap-
erones (Kim et al., 2012). In 2008, the mobA gene from C. testos-
teroni GZ39 coding for 3-hydroxybenzoate hydroxylase (3HB4H)
was cloned and subjected to directed evolution by error-prone
PCR. With only a single point mutation, the enzyme able to
hydroxylate phenolic acids was transformed into an enzyme that
can also act on phenol (Chang and Zylstra, 2008).
The recombinant expressions of the 3-hydroxybenzoate 6-
hydroxylase (3HB6H) from Pseudomonas alcaligenes NCIMB
9867 P25X and from Polaromonas naphthalenivorans CJ2 were
reported in 2005 and 2007, respectively (Gao et al., 2005; Park
et al., 2007). Recently, a 3HB6H from R. jostii RHA1 was cloned
in the pBAD/Myc-His vector, overexpressed in E. coli and char-
acterized biochemically (Montersino and van Berkel, 2012). This
FAD-dependent enzyme introduces the hydroxyl group in p-
position with respect to the previous OH on a series of o- or
m-substituted 3-hydroxybenzoate derivatives. In this study, the
authors performed a survey for flavin-dependent hydroxylases
in R. jostii RHA1 genome and found several hydroxylases that
belong to class A of flavoprotein monooxygenases (Montersino
and van Berkel, 2012). The crystal structure of the recombinant
3HB6H from R. jostii RHA1 was solved recently (Montersino
et al., 2013).
Due to their ability to oxidize monophenol to o-diphenol
compounds, 4-hydroxyphenylacetate 3-hydroxylases (HPAH) are
attractive biocatalysts (Lee and Xun, 1998). The enzymes are
two-component systems formed by reductase and hydroxylase
subunits. Thotsaporn et al. (2004) cloned each subunit in pET-11
derived vectors, expressed them in E. coli, and purified and char-
acterized the recombinant enzymes. Later, the E. coli W HPAH
was cloned in a pETDuet vector, expressed in E. coli BL21(DE3)
and the whole-cell system was used for the biotransformation
of 4-substituted halophenols to the corresponding catechols in
shake- flasks and in a 5 L bioreactor (Coulombel et al., 2011).
Another group of two-component flavin-dependent monooxy-
genases that catalyze the oxygenation of 4-hydroxyphenylacetate
is represented by the HPAH from P. aeruginosa. It was cloned,
expressed in E. coli and characterized. It was able to oxidize tyrosol
to hydroxytyrosol and various phenols (Chakraborty et al., 2010).
Recently, both genes coding for HPAH from P. aeruginosa PAO1
were cloned into a pETDuet-1 vector and expressed in E. coli cells.
Biotransformation of several compounds was tested in whole-cell
systems and the oxidation of p-coumaric acid to caffeic acid was
scaled-up both in the absence and in the presence of glucose or
glycerol by stepwise increases in substrate concentration in order
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to avoid substrate inhibition of the enzymatic activity (Furuya
and Kino, 2013).
OTHER REACTIONS CATALYZED BY FLAVOPROTEIN
MONOOXYGENASES
The oxidation of indole by microbial oxygenases has been studied
during the last 30 years (Ensley et al., 1983). Amongst the recom-
binant enzymes utilized for this purpose, phenol hydroxylases and
styrene monooxygenases are worth mentioning (Doukyu et al.,
2003; Gursky et al., 2010). An interesting application of indole
biooxidation by styrene monooxygenases was the development of
a colorimetric method for the screening of a directed evolution
library of styAB from P. putida CA-3 (Gursky et al., 2010).
Choi et al. (2003) showed the ability of the mFMO from
Methylophaga sp. SK1 to produce indigo in E. coli and, in the
presence of tryptophan, they could increase the production of
indigo up to 160mg/L. To further improve this process, the orig-
inal plasmid was subjected to deletions in the upstream region of
the fmo ORF from Methylophaga aminisulfidivorans MPT chro-
mosomal DNA previously cloned. The best producing strain was
selected and the composition of the medium as well as pH and
temperature for the production of indigo were optimized. As
result, the authors could produce 920mg/L of bio-indigo from
the recombinant E. coli cells (Han et al., 2008). In 2011, the same
research group reported the production of indigo in large scale
batch fermentation and in continuous cultivation from the above-
mentioned recombinant strain. The latter fermentation mode
allowed them to accumulate 23 g of bio-indigo in 110 h (Han
et al., 2011). The observation that cultures of cells producing the
fusion PTDH-mFMO turned blue motivated an investigation of
the ability of isolated PTDH-mFMO to synthesize some indigoid
derivatives and the results were readily visualized as different col-
ors of the reaction mixtures (Rioz-Martínez et al., 2011). The first
oxidation of indole catalyzed by a BVMOwas reported in 2007 for
the M446Gmutant of PAMO (Torres Pazmiño et al., 2007), when
cultures expressing this recombinant enzyme turned blue due to
the formation of indigo blue.
Some Type I BVMOs have also the ability to oxidize boron-
containing compounds (Branchaud and Walsh, 1985; Walsh and
Chen, 1988). In 2005, PAMO from T. fusca was shown to oxi-
dize phenylboronic acid to phenol (de Gonzalo et al., 2005b).
A year later the same research group reported a similar result
for HAPMO from P. fluorescens ACB (de Gonzalo et al., 2006b).
These studies were extended to a variety of boron-containing
acetophenones, vinyl boron compounds and racemic boron-
containing compounds and two other BVMOs were evaluated
(i.e., the PAMO M446G mutant and CHMOAcineto) (Brondani
et al., 2011). The chemoselectivity of the reactions was vari-
able and depended on the biocatalyst, being the boron oxida-
tion exclusively preferred over Baeyer-Villiger oxidation on 3-
substituted acetophenones for wild-type and M446G PAMO. The
selectivity between epoxidation and boron oxidation was investi-
gated in vinyl boron compounds and only boron oxidation was
reported in some cases. The excellent chemoselectivity of PAMO
was employed to attain the kinetic resolution of boron-containing
compounds giving chiral alcohols and chiral boron compounds
in high e.e. (Brondani et al., 2011). In a following report, the
enantioselectivity of the BVMOs for oxidative kinetic resolutions
of racemic cyclopropyl boronic esters, phenylethyl boronates, and
β-boronated carboxylic esters was investigated (Brondani et al.,
2012a). In addition, recombinant PAMO efficiently mediated
the chemoselective oxidation of some organoselenium acetophe-
nones to the corresponding selenoxides (Andrade et al., 2011)
and, a chiral selenium compound was afforded by the kinetic
resolution of a racemic selenium-containing aromatic compound
with high e.e. in a reaction mediated by PAMO (Brondani et al.,
2012b).
CONCLUDING REMARKS
Biocatalysis is an environmentally friendly strategy for the elab-
oration of fine chemicals, natural products or other biologically
active compounds. During the last decades enormous efforts have
been done to satisfy the demands of biocatalysts for organic
synthesis. However, multidisciplinary and coordinate work is
FIGURE 2 | General strategy for the development of recombinant
biocatalysts.
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still required to enlarge the repertoire of accessible reactions
and compounds. The development of recombinant biocatalysts
for organic synthesis and industrial applications involves mul-
tiple steps beginning from sequence selection up to biopro-
cess improvement (Figure 2). Aiming at describing and exem-
plifying this entire process, in the preceding sections we pre-
sented recent work and the state of the art on flavoprotein
monooxygenases-mediated reactions for the creation of selec-
tive and stable biocatalysts as well as robust biotransformation
processes. Bioinformatics analysis, recombinant DNA technology
and protein engineering methods are part of the basic toolkit
toward optimized redox biocatalysts. The sequence of interest
can derived from natural or synthetic origin. Once it is cloned,
selection of convenient expression vectors and improved hosts,
optimization of growing and induction media or conditions
and assisted protein folding can help reach proper recombinant
expression levels. Considering the critical requisite of flavoprotein
monooxygenases for cofactor recycling, activity of the biocatalysts
can be evaluated in formats ranging from whole-cell systems to
pure enzymes. Protein engineering techniques such as directed
evolution, rational re-design and de-novo design of enzymes allow
the expansion of the range of biocatalysts available and the devel-
opment of tailored enzymes. Innovations on solvent or reaction
medium engineering have also a huge impact on the biocat-
alytic outcome. Immobilization methods, strain improvement by
metabolic engineering, and scale-up procedures under fine bio-
process control are further valuable tools for the development of
a successful biocatalytic process for the industry.
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